<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: MicroRNAs regulate gene expression at the post-transcriptional level and play important roles in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development, progression, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate the expression of miR-92a in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and the <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent mucosa and its potential relevance to clinicopathological characteristics and patient survival </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Surgical specimens of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa were obtained from 82 patients with colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The relative expression levels of miR-92a <z:chebi fb="2" ids="33699">mRNA</z:chebi> in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and the <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent mucosa were measured by quantitative real-time reverse transcriptase polymerase chain reaction </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed their correlation with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e>, clinicopathologic parameters, and clinical outcome </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The relative expression levels of miR-92a were significantly higher in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues than in the <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent mucosa (p &lt; 0.001), and a high expression of miR-92a correlated with advanced clinical stage (p = 0.025), <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> (p = 0.015), and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (p = 0.046) </plain></SENT>
<SENT sid="6" pm="."><plain>Kaplan-Meier analysis indicated that patients with high miR-92a expression had a poor overall survival (p = 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, multivariate analysis showed that increased expression of miR-92a was an independent predictor of overall survival </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: This study revealed that miR-92a overexpression was correlated with specific <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> biopathologic features, such as TNM stage, lymph node and distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, and poor survival of the patients, indicating that miR-92a may serve as a molecular prognostic marker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and disease progression </plain></SENT>
</text></document>